Search PDMR transactions

Notifier
Name of person with notification obligation
Bent Frandsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Bent Frandsen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Expres2ion Biotech Holding AB
Issuer´s LEI code
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share ExpreS2ion Biotech Holding AB SE0023261292 Acquisition 12,000 Quantity 1.19 SEK 01/10/2026 FIRST NORTH SWEDEN
Share ExpreS2ion Biotech Holding AB SE0023261292 Acquisition 8,000 Quantity 1.15 SEK 02/10/2026 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding AB SE0023261292 Acquisition 01/10/2026 FIRST NORTH SWEDEN 12,000 (Quantity) 1.19 SEK
ExpreS2ion Biotech Holding AB SE0023261292 Acquisition 02/10/2026 FIRST NORTH SWEDEN 8,000 (Quantity) 1.15 SEK
Total: 20,000
<< Back